Several types of antidiabetic drugs, including metformin, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors, were also associated with the normalization of enzyme levels in NAFLD by inhibiting liver inflammation and improving insulin resistance [46, 47]. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.